Study Site 022 — Fort Worth, Texas

Study Site 022 is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Study Site 022 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hypoxic-Ischemic Encephalopathy.

Sponsors: ReAlta Life Sciences, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 022?

Study Site 022 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 022 conducted?

Study Site 022 has 1 clinical trials on record, with 1 currently active. Their work covers Hypoxic-Ischemic Encephalopathy.

Is Study Site 022 accredited by Crixeo Health?

Study Site 022 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 022?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.